🇺🇸 FDA

Intelligence · Clinical Pipeline

CORCEPT THERAPEUTICS Pipeline

All ClinicalTrials.gov programs at CORCEPT THERAPEUTICS — phase, modality, and trial IDs.

Programs
67

Quick answer

CORCEPT THERAPEUTICS has 67 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Mifepristone and Eribulin in combination

    CORCEPT THERAPEUTICS INC

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  2. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  3. Miricorilant

    CORCEPT THERAPEUTICS INC

    Antipsychotic Induced Weight Gain

    phase 1 small molecule completed

    1 trial

  4. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  5. Miricorilant 300 mg tablets

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  6. Miricorilant Treatment A

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Olanzapine

    CORCEPT THERAPEUTICS INC

    Antipsychotic-induced Weight Gain

    phase 1 small molecule completed

    1 trial

  8. Relacorilant

    CORCEPT THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  9. Relacorilant

    CORCEPT THERAPEUTICS INC

    Adrenocortical Carcinoma

    phase 1 small molecule completed

    1 trial

  10. Relacorilant

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  11. Relacorilant (3x100 mg softgel capsules)

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  12. Relacorilant 350mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  13. Relacorilant Fasted

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  14. Relacorilant under fasted conditions

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Risperidone

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  16. [14C]-CORT113176

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  17. [14C]-CORT125134

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  18. mifepristone + fluvastatin

    CORCEPT THERAPEUTICS INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  19. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does CORCEPT THERAPEUTICS have?

67 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.